Beijing Leadman Biochemistry Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 356.09 million compared to CNY 235.75 million a year ago. Revenue was CNY 374.28 million compared to CNY 245.52 million a year ago.

Net income was CNY 23.94 million compared to CNY 13.56 million a year ago. Basic earnings per share from continuing operations was CNY 0.044 compared to CNY 0.0325 a year ago. Diluted earnings per share from continuing operations was CNY 0.044 compared to CNY 0.0325 a year ago.